Related Experiment Video

Updated: May 3, 2026

Micro-dissection of Enamel Organ from Mandibular Incisor of Rats Exposed to Environmental Toxicants
08:12

Micro-dissection of Enamel Organ from Mandibular Incisor of Rats Exposed to Environmental Toxicants

Published on: March 29, 2018

9.8K

Global developmental delay with sodium valproate-induced gingival hyperplasia

Ravi B Patil1, Pallavi Urs, Shital Kiran

  • 1Department of Pedodontics and Preventive Dentistry, Rajiv Gandhi Dental College & Hospital, Bangalore, Karnataka, India.

BMJ Case Reports
|January 24, 2014
PubMed

Insights

This case study highlights a 5-year-old child with global developmental delay and infantile spasms treated with sodium valproate. It focuses on the rare occurrence of sodium valproate-induced gingival enlargement in a child with developmental delay.

Area of Science:

  • Pediatric Neurology
  • Developmental Pediatrics
  • Pharmacology

Background:

  • Global developmental delay (GDD) is characterized by impaired development across multiple domains.
  • Infantile spasms are a severe form of epilepsy in infants.
  • Sodium valproate is a common antiepileptic drug used in pediatric cases.

Observation:

  • A 5-year-old child presented with GDD, infantile spasms, and poor oral hygiene.
  • The child was undergoing treatment with sodium valproate for epilepsy.
  • Significant gingival enlargement was noted as a primary concern.

Findings:

  • The case details a child with GDD and infantile spasms.
  • Sodium valproate treatment was associated with the development of gingival enlargement.
  • This represents a specific instance of drug-induced side effects in a pediatric patient with GDD.

Implications:

  • Highlights the importance of monitoring oral health in children treated with sodium valproate.
  • Suggests a potential link between GDD, epilepsy treatment, and adverse oral conditions.
  • Emphasizes the need for comprehensive care addressing both neurological and pharmacological aspects in children with developmental disorders.

More Related Videos

Author Spotlight: Studying Clinical Characters and Epilepsy Outcomes After Frontal Disconnection in Patients with MOGHE06:04

Author Spotlight: Studying Clinical Characters and Epilepsy Outcomes After Frontal Disconnection in Patients with MOGHE

Published on: August 16, 2024

1.8K
A Novel Approach to Monitoring Graft Neovascularization in the Human Gingiva07:51

A Novel Approach to Monitoring Graft Neovascularization in the Human Gingiva

Published on: January 12, 2019

6.3K

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.2K
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.7K
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
65
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
15.2K